Health Care Policy

Stony Brook Medicine is the premier academic healthcare system, integrating patient care, education, and research to the 9 million residents of Long Island. Our hospitals serve as Suffolk County's only Level 1 Adult and Pediatric Trauma Center. Stony Brook Medicine includes four hospitals, over 200 community-based ambulatory healthcare locations, 350-bed skilled nursing facility for veterans, children’s hospital, cancer center, neurosciences institute, heart institute and trauma center.

Stony Brook Medicine’s Renaissance School of Medicine is ranked #1 among public schools in NY state for National Institutes of Health (NIH) funding with almost 260 active clinical trials. Since 2004, NIH awards to SBM increased by over 46%, which has placed RSOM among the top 50th percentile of US medical schools for NIH Our staff conduct research and care for patients while also training the next generation of medical professionals.

Our Government Relations team works to strengthen Stony Brook Medicine's relationships with federal, state, and local leaders, keeping our elected officials informed about the impact of our clinical care, health and medical research, and health workforce training and educational goals. Through our ongoing efforts, our team helps to keep both our elected officials and the local community informed about the exceptional health care services, education and training and clinical research offered through Stony Brook Medicine. 

Contacts

Michelle Greenhalgh

Director of Federal Healthcare Policy & Advocacy, Medicine

Amy Ellis

Director of Government Relations

 

Stony Brook Medicine Legislative Priorities

Explore recommendations for fiscal year 2027

Overview

With its 4 hospitals, over 200 community-based ambulatory healthcare locations, 350-bed skilled nursing facility for veterans, children’s hospital, cancer center, neurosciences institute, heart institute and trauma center, Stony Brook Medicine (SBM) provides world-class healthcare to the 9 million residents of Long Island.

SBM’s Renaissance School of Medicine (RSOM) is ranked #1 among public schools in NY state for National Institutes of Health (NIH) funding with almost 260 active clinical trials. Since 2004, NIH awards to SBM increased by over 46%, which has placed RSOM among the top 50th percentile of US medical schools for NIH Our staff conduct research and care for patients while also training the next generation of medical professionals.

In addition to providing healthcare to the community, SBM is a strong contributor to the Long Island economy in that it provides almost 10,000 highly coveted hospital jobs for Long Island From February 2025 to January 2026, Stony Brook Medicine hired almost 1,500 new employees.

Priority #1 – Provide Fiscal Stability & Security for Safety Net Hospitals

  • Repeal the catastrophic Medicaid Disproportionate Share Hospital (DSH) cuts that take effect on October 1, 2027, totaling $8 billion nationally, $1.3 billion to New York state, and $135 million to Stony Brook University Hospital.
  • Reverse harmful Medicaid reimbursement cuts included in H.R. 1, the One Big Beautiful Bill Act (P.L. 119-21) which cut Medicare and Medicaid reimbursement to safety net hospitals, including reducing the state cap on provider taxes and allowing DSH payment reductions starting in calendar year 2026. For NY, H.R.1 resulted in $8 billion in annual lost hospital revenue, cost 34,000 hospital jobs and 29,000 non-hospital jobs and $14.4 billion in lost hospital-generated economic activity.
  • Ensure Payment of Outstanding FEMA COVID-19 Claims – SBM incurred roughly $175 million in covid-related costs through 2022. Due to issues between NY and FEMA, SBM and the SUNY system are still awaiting payment for the remaining balance of owed COVID-19 claims.

Priority #2 – Strengthen & Protect the Healthcare Workforce

  • Invest in clinical training sites, create career pathway programs, and waive new H-1B and J-1 visa fees for immigrant healthcare workers to help hospitals recruit adequate clinical staff from abroad to bolster the supply of nurses and ancillary staff.
  • Pass the Resident Physician Shortage Reduction Act (S.2439/H.R.4731), which would add 14,000 Medicare-supported residency positions over seven years prioritizing underserved areas and helping to address the ongoing workforce shortage and projected 86,000 doctor shortage by 2036.
  • Pass the Healthcare Workforce Resilience Act (S.2759/H.R.5283), which would recapture green cards that were previously authorized by Congress but were unused by allotting up to 25,000 unused immigrant visas for nurses and 15,000 unused immigrant visas for physicians.
  • Pass the Conrad State 30 and Physician Access Reauthorization Act (S.709/H.R.1585), a bill that provides a three-year reauthorization for the Conrad State 30 program, which allows foreign-born medical graduates to practice medicine in rural and underserved areas. The legislation also expands the program increasing current state allocations from 30 to 35 physicians per year. The bill also increases flexibility to expand the number of waivers in states where physician demand exceeds the state limits.
  • Strengthen workplace safety by enacting federal protections for healthcare workers against violence and intimidation, including passing the Safety from Violence for Healthcare Employees (SAVE) Act (S.1600/H.R.3178). Additionally, provide hospitals with grant funding for education and training programs and coordination efforts with state and local law enforcement.

Priority #3 – Commercial Insurer Accountability

  • Hold commercial health insurers accountable for ensuring appropriate patient access to care, including by reducing the excessive use of prior authorization, ensuring adequate provider networks, limiting inappropriate denials for services that should be covered, and prohibiting certain specialty pharmacy policies, like insurer-mandated “white bagging,” that create patient safety risks and limit patient access to certain medications in hospital settings.
  • Streamline prior authorization policies and operations to facilitate patients’ access to timely care, reduce burdens on health care providers and lower health care administrative costs.
  • Ensure patients can rely on their coverage by disallowing health plans from inappropriately delaying and denying care, including by making unilateral mid-year coverage changes.
  • Ensure prompt payment from insurers for medically necessary, covered health care services.
  • Increase oversight and accountability of commercial health plans through increased data collection, reporting and transparency on core plan performance metrics that are meaningful indicators of patient access, such as appeals, denials and grievances.

Priority #4 – Enhance Access to Care 

  • Make Covid-era Medicare telehealth flexibilities and payment policies permanent, including lifting geographic and originating site restrictions, expanding the types of practitioners who can provide telehealth and removing the in-person visit requirements for tele-mental health services via the CONNECT for Health Act (S.1261/H.R.4206).
  • Create a pathway to adequate Medicare reimbursement for hospitals that operate Mobile Stroke Units (MSUs). Intervention and treatment of a stroke via MSU show significantly improved outcomes for acute ischemic stroke patients by enabling prehospital thrombolysis, which results in substantial time savings and potential benefits to outcomes, particularly in urban settings. Patients transported to the hospital via MSU increased golden-hour rates from less than 5% with standard EMS care to 21-33% (Aderinto N, 2025).
  • Remove barriers to online medical appointment booking via the Health Accelerating Consumers; Care by Expediting Self-Scheduling (ACCESS) Act (S.1140).

Coming soon ...

Fast Stats

Stony Brook University Hospital

115,117

Emergency Department Visits

1,422,098

Outpatient Visits

8,127

Employees

 

 

 

Stony Brook Medicine HHS Health Research Funding

FY 2025 - FY 2026 Total Award Funding $100.2 million



Key Takeaways 

Stony Brook Medicine secured more than $100 million in HHS-sponsored research funding, with NIH accounting for nearly four out of every five federal research dollars. 

Funding mix
  • NIH: $78,709,368
  • CDC: $14,977,218
  • HRSA: $6,154,807
  • HHS (Other): $351,980

NIH funding represents 78.6% of total HHS-sponsored research support, demonstrating Stony Brook Medicine's strong national competitiveness in biomedical research, scientific discovery, and health innovation. 

Funding by agency graphic showing 79% of total funding from NIH

 

Strategic Partnerships

Stony Brook Medicine is proud to belong to and work with the following organizations.